Qvr LLC Gilead Sciences, Inc. Put Options Transaction History

Qvr LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 10, 2023	SELL	$62.32 - $89.47 $1.5 Million - $2.15 Million	-24,000 Reduced 88.89%	3,000 $257,000
Q3 2022 Oct 25, 2022	BUY	$59.54 - $68.01 $345,332 - $394,458	5,800 Added 27.36%	27,000 $1.67 Million
Q2 2022 Aug 01, 2022	SELL	$57.72 - $65.01 $1.64 Million - $1.85 Million	-28,400 Reduced 57.26%	21,200 $1.31 Million
Q1 2022 Apr 27, 2022	BUY	$57.92 - $72.58 $1.15 Million - $1.44 Million	19,900 Added 67.0%	49,600 $2.95 Million
Q3 2021 Nov 02, 2021	BUY	$67.69 - $73.03 $1.48 Million - $1.59 Million	21,800 Added 275.95%	29,700 $2.08 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $266,574 - $291,270	4,200 Added 113.51%	7,900 $545,000
Q1 2021 May 03, 2021	BUY	$60.0 - $68.46 $222,000 - $253,301	3,700 New	3,700 $239,000

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Qvr LLC, based on Form 13F filings with the SEC.

Stay updated on Qvr LLC with notifications on news.